3[1]Pinho MG, Filipe SR, Lencastre H, et al. Complementation of the essential peptidoglycan transpeptidase function of penicillin-binding protein 2 (PBP2) by the drug resistance protein PBP2A in Staphylococcus aureus[J]. J Bacteriol, 2001, 183(22): 6525-6531.
4[2]Goldmann DA, Weinstein RA, Wenzel RP, et al. Strategies to prevent and control the emergence and spread of microorganisms in hospitals[J]. JAMA, 1996, 275(3): 234.
5[5]Krcmery V, Sykora P, Trupl J, et al. Antibiotic use and development of resistance in blood culture isolates: 8 years of experience from a cancer referral center[J]. J Chemother, 2001, 13(2): 133-142.
6[6]Rojas H, Fernandez LN, Espino HM, et al. Patterns of drug resistance in Staphylococcus aureus from human clinical isolates[J]. Rev Cubana Med Trop, 2001, 53(1): 53-58.
6Livengood CH.Bacterial vaginosis: an overview for 2009[J].Rev Obstet Gynecol, 2009, 2 ( 1 ) : 28-37.
7Clinical and Laboratory Stand ards Institute.Performance stand ards for antimicrobialsusceptibilitytesting[S].MlO0-S22, CLSI, 2012.
8Park JS, Cho DH, Yang JH, et al. Usefulness of a rapid real- time PCR assay in prenatal screening for group B streptococcus colonization[J].Ann Lab Med, 2013, 33 ( 1 ) : 39-44.
9Van Dyke MK, Phares CR, LytLfield R, et al.Evaluation of universal antenatal screening for group B streptococcus [J].N Engl J Med, 2009, 360 (25) : 2626-2636.
10Verani JR, McGee L, Schrag SJ. Prevention of perinatal group B streptococcal disease-revised guidelines from CDC, 2010[J].MMWR Recomm Rep, 2010, 59 (RR-10) : 1-36.
